scholarly article | Q13442814 |
P50 | author | Srinivas Sriramula | Q60310610 |
Colin Sumners | Q64025382 | ||
P2093 | author name string | Michael J Katovich | |
Mohan K Raizada | |||
Qiuhong Li | |||
Peng Shi | |||
Joseph Francis | |||
Yanfei Qi | |||
Joo Yun Jun | |||
Carlos Diez-Freire | |||
P2860 | cites work | IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease | Q28574673 |
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII | Q28576309 | ||
The sympathetic control of blood pressure | Q30440682 | ||
Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. | Q33214096 | ||
Microglia: activation and their significance in the central nervous system | Q34324201 | ||
Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use | Q34455914 | ||
Clinical potential of minocycline for schizophrenia | Q34875176 | ||
Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives | Q35045333 | ||
Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease | Q36511499 | ||
Brain cytokines as neuromodulators in cardiovascular control | Q36810335 | ||
Macrophage migration inhibitory factor in hypothalamic paraventricular nucleus neurons decreases blood pressure in spontaneously hypertensive rats | Q36841742 | ||
Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension | Q37193534 | ||
Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. | Q37211166 | ||
Protective autoimmunity in the nervous system | Q37322795 | ||
Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy | Q37330943 | ||
Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion | Q37342681 | ||
Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease | Q37550803 | ||
Phosphate-activated glutaminase-containing neurons in the rat paraventricular nucleus express angiotensin type 1 receptors | Q42075864 | ||
Regulation of renin gene expression by oxidative stress | Q42550738 | ||
Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures | Q44595496 | ||
Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system | Q44932501 | ||
Angiotensin II receptor 1 involved in the central pressor response induced by interleukin-1 beta in the paraventricular nucleus | Q46223876 | ||
Central gene transfer of interleukin-10 reduces hypothalamic inflammation and evidence of heart failure in rats after myocardial infarction | Q48135880 | ||
TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats | Q48212660 | ||
Loss of inhibitory synapses on the soma and axon initial segment of pyramidal cells in human epileptic peritumoural neocortex: implications for epilepsy. | Q55478954 | ||
Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3 | Q68861257 | ||
Activation of sympathetic outflow by recombinant human interleukin-1 beta in conscious rats | Q71464058 | ||
Chronic low-dose angiotensin II infusion increases venomotor tone by neurogenic mechanisms | Q79137201 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microglia | Q1622829 |
hypertension | Q95566669 | ||
P304 | page(s) | 297-303 | |
P577 | publication date | 2010-06-14 | |
P1433 | published in | Hypertension | Q5958695 |
P1476 | title | Brain microglial cytokines in neurogenic hypertension | |
P478 | volume | 56 |
Q41606021 | A Single Angiotensin II Hypertensive Stimulus Is Associated with Prolonged Neuronal and Immune System Activation in Wistar-Kyoto Rats |
Q98388019 | ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2 |
Q40159156 | ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke |
Q48287214 | Acetylcholinesterase Inhibition Attenuates the Development of Hypertension and Inflammation in Spontaneously Hypertensive Rats. |
Q35841988 | Activation of central PPAR-γ attenuates angiotensin II-induced hypertension. |
Q40646132 | Aerobic training normalizes autonomic dysfunction, HMGB1 content, microglia activation and inflammation in hypothalamic paraventricular nucleus of SHR. |
Q38826410 | Altered neurotrophic factors' expression profiles in the nucleus of the solitary tract of spontaneously hypertensive rats |
Q89673334 | Amphetamine-induced sensitization of hypertension and lamina terminalis neuroinflammation |
Q27013715 | An update on immune system activation in the pathogenesis of hypertension |
Q42005488 | Ang II-salt hypertension depends on neuronal activity in the hypothalamic paraventricular nucleus but not on local actions of tumor necrosis factor-α. |
Q54230202 | Angiotensin II Type 1a Receptors in the Subfornical Organ Modulate Neuroinflammation in the Hypothalamic Paraventricular Nucleus in Heart Failure Rats. |
Q40212788 | Angiotensin Receptor Blockade Modulates NFκB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition |
Q46310472 | Angiotensin Receptor Blockade by Inhibiting Glial Activation Promotes Hippocampal Neurogenesis Via Activation of Wnt/β-Catenin Signaling in Hypertension. |
Q42392453 | Angiotensin Type-2 Receptors Influence the Activity of Vasopressin Neurons in the Paraventricular Nucleus of the Hypothalamus in Male Mice |
Q36800850 | Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against diet-induced obesity. |
Q38577750 | Angiotensin-II, the Brain, and Hypertension: An Update |
Q52676262 | Assessing the role of hypothalamic microglia and blood vessel disruption in the development of angiotensin II-dependent hypertension in Cyp1a1-Ren2 rats. |
Q48489132 | Astrocytes Contribute to Angiotensin II Stimulation of Hypothalamic Neuronal Activity and Sympathetic Outflow. |
Q38163818 | Autoimmunity in the pathogenesis of hypertension |
Q27026889 | Autonomic nervous system and immune system interactions |
Q35856337 | Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease |
Q22306336 | Autonomic-Immune-Vascular Interaction: An Emerging Concept for Neurogenic Hypertension |
Q40081529 | Beyond gut feelings: how the gut microbiota regulates blood pressure. |
Q36882293 | Bidirectional neuro-glial signaling modalities in the hypothalamus: role in neurohumoral regulation |
Q57459521 | Blockade of Endogenous Angiotensin-(1-7) in Hypothalamic Paraventricular Nucleus Attenuates High Salt-Induced Sympathoexcitation and Hypertension |
Q47699200 | Blood-borne Interleukin-1β Acts upon the Subfornical Organ to Upregulate the Sympathoexcitatory Milieu of the Hypothalamic Paraventricular Nucleus |
Q61443992 | Blood-brain barrier permeability and physical exercise |
Q48200626 | Brain Transforming Growth Factor-β Resists Hypertension Via Regulating Microglial Activation |
Q38100285 | Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system |
Q92097275 | Brain angiotensin type-1 and type-2 receptors: cellular locations under normal and hypertensive conditions |
Q35776904 | Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension |
Q35166544 | Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats |
Q26825054 | Brain inflammation and hypertension: the chicken or the egg? |
Q91345285 | Brain perivascular macrophages: connecting inflammation to autonomic activity in hypertension |
Q35990719 | Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics |
Q41882282 | Brain-mediated dysregulation of the bone marrow activity in angiotensin II-induced hypertension |
Q35079417 | Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation |
Q90675584 | CD4+ Regulatory T Lymphocytes Prevent Impaired Cerebral Blood Flow in Angiotensin II-Induced Hypertension |
Q34898890 | Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress |
Q90143428 | Central CYP1B1 (Cytochrome P450 1B1)-Estradiol Metabolite 2-Methoxyestradiol Protects From Hypertension and Neuroinflammation in Female Mice |
Q64079080 | Central Inhibition of Tumor Necrosis Factor Alpha Reduces Hypertension by Attenuating Oxidative Stress in the Rostral Ventrolateral Medulla in Renovascular Hypertensive Rats |
Q36805385 | Central Renin-Angiotensin System Activation and Inflammation Induced by High-Fat Diet Sensitize Angiotensin II-Elicited Hypertension. |
Q34627822 | Central SDF-1/CXCL12 expression and its cardiovascular and sympathetic effects: the role of angiotensin II, TNF-α, and MAP kinase signaling |
Q35680234 | Central TNF inhibition results in attenuated neurohumoral excitation in heart failure: a role for superoxide and nitric oxide. |
Q36006333 | Central actions of the chemokine stromal cell-derived factor 1 contribute to neurohumoral excitation in heart failure rats |
Q35601234 | Central angiotensin II has catabolic action at white and brown adipose tissue |
Q42229127 | Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension |
Q35898242 | Central blockade of salusin β attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats |
Q41881875 | Central mechanisms of abnormal sympathoexcitation in chronic heart failure |
Q58600393 | Central nervous system neuroplasticity and the sensitization of hypertension |
Q27021580 | Central neuromodulatory pathways regulating sympathetic activity in hypertension |
Q92711868 | Chemoattraction and Recruitment of Activated Immune Cells, Central Autonomic Control, and Blood Pressure Regulation |
Q28384259 | Chronic estrogen exposure affects gene expression in the rostral ventrolateral medulla of young and aging rats: Possible role in hypertension |
Q33842137 | Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier |
Q38781945 | Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension. |
Q38637276 | Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension |
Q90533496 | Contribution of Oxidative Stress and Inflammation to the Neurogenic Hypertension Induced by Intermittent Hypoxia |
Q36699626 | Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus |
Q50533718 | Differential effect of angiotensin II and blood pressure on hippocampal inflammation in mice. |
Q37232659 | Differential effects of homotypic vs. heterotypic chronic stress regimens on microglial activation in the prefrontal cortex. |
Q36395947 | Direct anti-inflammatory effects of angiotensin-(1-7) on microglia |
Q34323132 | Direct pro-inflammatory effects of prorenin on microglia |
Q38110197 | Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension. |
Q36849547 | Early interference with p44/42 mitogen-activated protein kinase signaling in hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension |
Q90351956 | Elevated Oxidative Stress and Inflammation in Hypothalamic Paraventricular Nucleus Are Associated With Sympathetic Excitation and Hypertension in Rats Exposed to Chronic Intermittent Hypoxia |
Q38265707 | Endocan: a new molecule playing a role in the development of hypertension and chronic kidney disease? |
Q38922258 | Evidence that remodeling of insular cortex neurovascular unit contributes to hypertension-related sympathoexcitation |
Q41847076 | Excessive leukotriene B4 in nucleus tractus solitarii is prohypertensive in spontaneously hypertensive rats |
Q50096401 | Experimental Evidences Supporting Training-Induced Benefits in Spontaneously Hypertensive Rats. |
Q39334578 | Factors Responsible for Obesity-Related Hypertension. |
Q34972079 | Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease |
Q28066122 | Glia, sympathetic activity and cardiovascular disease |
Q59353758 | Glutamatergic neurons of the paraventricular nucleus are critical contributors to the development of neurogenic hypertension |
Q34669297 | Gut dysbiosis is linked to hypertension. |
Q89548582 | Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide |
Q93005740 | Hypertension as a Metabolic Disorder and the Novel Role of the Gut |
Q36838219 | Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent |
Q38774292 | Hypothalamic and inflammatory basis of hypertension |
Q38296186 | IL-10 gene transfer upregulates arcuate POMC and ameliorates hyperphagia, obesity and diabetes by substituting for leptin |
Q88803579 | Immune cell trafficking, lymphatics and hypertension |
Q36733839 | Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective Commentary |
Q36458390 | Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension - A case report. |
Q89273091 | Impact of swimming exercise on inflammation in medullary areas of sympathetic outflow control in spontaneously hypertensive rats |
Q90950050 | Importance of the commissural nucleus of the solitary tract in renovascular hypertension |
Q35696855 | Increased angiotensin II-induced hypertension and inflammatory cytokines in mice lacking angiotensin-converting enzyme N domain activity |
Q26827525 | Inflammation, immunity, and hypertensive end-organ damage |
Q64906046 | Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis. |
Q34731058 | Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension |
Q92983814 | Inhibition of inflammation by minocycline improves heart failure and depression-like behaviour in rats after myocardial infarction |
Q52448624 | Insights into innate immune signalling in controlling cardiac remodelling. |
Q98224393 | Interactions of the Brain Renin-Angiotensin-System (RAS) and Inflammation in the Sensitization of Hypertension |
Q41546343 | Interleukin-1 mediates neuroinflammatory changes associated with diet-induced atherosclerosis |
Q36764100 | Interleukin-10 inhibits angiotensin II-induced decrease in neuronal potassium current |
Q91013940 | Intracerebroventricular administration of bone marrow-derived cells attenuates angiotensin II-initiated neurogenic hypertension in rats |
Q90685029 | Involvement of Microglial Cells in Hypoxia-induced Pulmonary Hypertension |
Q88523651 | Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension |
Q35815641 | Involvement of bone marrow cells and neuroinflammation in hypertension. |
Q64093985 | Is Aberrant Reno-Renal Reflex Control of Blood Pressure a Contributor to Chronic Intermittent Hypoxia-Induced Hypertension? |
Q42872654 | Is microglia the new target for the treatment of resistant hypertension? |
Q47644016 | Kinin B1 Receptor Promotes Neurogenic Hypertension Through Activation of Centrally Mediated Mechanisms. |
Q47194645 | Maintenance of Blood-Brain Barrier Integrity in Hypertension: A Novel Benefit of Exercise Training for Autonomic Control. |
Q37278850 | Mechanisms underlying prorenin actions on hypothalamic neurons implicated in cardiometabolic control |
Q38916635 | Microglia and Monocyte-Derived Macrophages in Stroke |
Q54357518 | Microglia are selectively activated in endocrine and cardiovascular control centres in streptozotocin-induced diabetic rats. |
Q40856027 | Microglia participate in neurogenic regulation of hypertension |
Q35437365 | Modulation of angiotensin II signaling following exercise training in heart failure |
Q38007859 | Neurogenic hypertension and elevated vertebrobasilar arterial resistance: is there a causative link? |
Q38013692 | Neurogenic hypertension: revelations from genome-wide gene expression profiling |
Q36824063 | Neuroimmune communication in hypertension and obesity: a new therapeutic angle? |
Q92512510 | Neuroimmune crosstalk in the pathophysiology of hypertension |
Q36292908 | Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation |
Q41506900 | Neuroinflammation contributes to autophagy flux blockage in the neurons of rostral ventrolateral medulla in stress-induced hypertension rats |
Q34205701 | Neuroinflammation in pulmonary hypertension: concept, facts, and relevance |
Q37139426 | Neuroinflammatory and autonomic mechanisms in diabetes and hypertension. |
Q90046724 | New Molecules for Treating Resistant Hypertension: a Clinical Perspective |
Q39040850 | Novel Pathophysiological Mechanisms in Hypertension |
Q34017275 | Obesity induces neuroinflammation mediated by altered expression of the renin-angiotensin system in mouse forebrain nuclei. |
Q27693855 | Obstructive sleep apnea and insight into mechanisms of sympathetic overactivity |
Q43446462 | Obstructive sleep apnea is associated with altered midbrain chemical concentrations |
Q41943162 | Oxidative stress in the brain causes hypertension via sympathoexcitation |
Q35696867 | Peroxisome proliferator-activated receptor-γ regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure. |
Q26825107 | Potential clinical application of recently discovered brain mechanisms involved in hypertension |
Q35365432 | Proinflammatory cytokines upregulate sympathoexcitatory mechanisms in the subfornical organ of the rat. |
Q39455507 | Recent Advances in Neurogenic Hypertension: Dietary Salt, Obesity, and Inflammation |
Q38122303 | Regulation of the sympathetic nervous system by nitric oxide and oxidative stress in the rostral ventrolateral medulla: 2012 Academic Conference Award from the Japanese Society of Hypertension |
Q49997121 | Renal effects of cytokines in hypertension. |
Q35656144 | Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system |
Q28081615 | Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control |
Q39342382 | Role of the Immune System in Hypertension |
Q57822871 | Rostral Ventrolateral Medulla and Hypertension |
Q47706847 | Salt, Hypertension, and Immunity. |
Q34047021 | Sex-specific T-cell regulation of angiotensin II-dependent hypertension |
Q47396920 | Short hairpin RNA interference targeting interleukin 1 receptor type I in the paraventricular nucleus attenuates hypertension in rats |
Q30612033 | Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease |
Q37162622 | Subfornical organ mediates sympathetic and hemodynamic responses to blood-borne proinflammatory cytokines. |
Q38717874 | Sympathetic-mediated activation versus suppression of the immune system: consequences for hypertension. |
Q89723169 | Systemic administration of pentoxifylline attenuates the development of hypertension in renovascular hypertensive rats |
Q36031902 | Systemic leukotriene B4 receptor antagonism lowers arterial blood pressure and improves autonomic function in the spontaneously hypertensive rat. |
Q52150609 | Targeting Interleukin-1 beta to Suppress Sympathoexcitation in Hypothalamic Paraventricular Nucleus in Dahl Salt-Sensitive Hypertensive Rats. |
Q38936618 | Targeting cytokine signaling in salt-sensitive hypertension |
Q89451828 | Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension? |
Q37825120 | The central nervous system and inflammation in hypertension |
Q37433886 | The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension |
Q62632794 | The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease |
Q46238640 | The immunology of hypertension. |
Q38074245 | The mosaic theory revisited: common molecular mechanisms coordinating diverse organ and cellular events in hypertension |
Q39157390 | The role of macrophages in hypertension and its complications |
Q37898511 | The sympathetic nervous system and blood pressure in humans: implications for hypertension |
Q35110074 | Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension |
Q35220244 | Toll-like receptor 4 promotes autonomic dysfunction, inflammation and microglia activation in the hypothalamic paraventricular nucleus: role of endoplasmic reticulum stress |
Q40062141 | Ultrastructural characterization of tumor necrosis factor alpha receptor type 1 distribution in the hypothalamic paraventricular nucleus of the mouse |
Q41664884 | Update on angiotensin II: new endocrine connections between the brain, adrenal glands and the cardiovascular system |
Q35939300 | Vascular inflammatory cells in hypertension |
Search more.